ArticleOncotarget2015

Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy.

Wen Wen Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.